Researchers have discovered a safe antimalarial dye that kills malaria parasites at an unprecedented rate, curing patients within two days. The addition of methylene blue to artemisinin-based combination therapies prevents the spread of malaria, with male parasites disappearing from the bloodstream more quickly than female parasites.
A comprehensive genetic study reveals that multidrug-resistant malaria parasites emerged and spread aggressively in Cambodia, under-reporting for years. Ongoing genomic surveillance is vital to inform public health malaria control strategies and detect patterns of resistance.
Researchers from Singapore University of Technology & Design (SUTD) and CSIR-National Chemical Laboratories (NCL) completed phenotypic screening of the MMV Malaria Box against Plasmodium falciparum and Toxoplasma gondii, identifying 24 molecules with nanomolar potency against both parasites.
Researchers employed AI 'scientist' Eve to discover that triclosan inhibits DHFR, an enzyme target of well-established antimalarial drug pyrimethamine; targeting this enzyme could help combat resistance
A study published in Veterinary Record found that commercial raw meat diets (RMDs) are contaminated with zoonotic bacteria and parasites, which can be transmitted to humans. The research highlights the need for pet owners to be aware of these risks and take proper hygiene measures to minimize exposure.
A study identified new drug targets and resistance genes in malaria parasites resistant to 37 diverse antimalarial compounds. The research, published in Science, revealed a complex chemogenetic landscape of the parasite's underlying biology.
Researchers have identified a common phospholipid pathway in plants and parasites, including malaria-causing Plasmodium. This discovery may lead to the development of new therapies for parasitic infections. The study also revealed that plant enzymes with similar structures can play different roles in the plant.
A team of researchers identified a molecular mechanism leading to ART treatment failures in malaria parasites, finding that blocking a specific stress pathway prevents latent stage entry. This breakthrough could lead to the development of new approaches to combat malaria by preventing treatment failure.
A team of researchers from the University of Pennsylvania has discovered a molecule that can suppress the lethal form of infection in a mouse model of Strongyloides stercoralis. By using this molecule, they were able to prevent the formation of larvae that trigger a persistent cycle of infection in the host.
Researchers found that limiting a nutrient used by malaria parasites can prevent the emergence of drug-resistant strains. This ecological approach shows promise for controlling drug resistance in infections like tuberculosis and malaria.
A research group at Osaka University has identified key molecules involved in severe malaria. The study found that RIFIN proteins expressed on infected erythrocytes suppress the host immune response by binding to an inhibitory receptor, contributing to the pathogenesis of severe malaria.
Scientists demonstrate that Leishmania adaptation results from frequent and reversible chromosomal amplifications, which enables the parasite to maintain genetic diversity while selecting for new alleles. This study has important consequences for understanding human Leishmania infection and identifying parasite drug resistance mechanisms.
A recent study by a University of Pennsylvania School found that wild bonobos are susceptible to various Plasmodium malaria parasites, including a previously unknown species. This discovery informs our understanding of the life cycle and transmission of malaria in humans.
Researchers at the University of Edinburgh identified a previously unknown mechanism by which immune responses are regulated. The discovery found that Th2 cells express EGFR, releasing defense molecules only in response to parasites, preventing tissue damage.
A recent study has identified a fatty molecule in human blood that controls the malaria parasite's decision to switch from replicating in humans to transmitting to mosquitoes. This discovery improves understanding of a critical stage in the Plasmodium life cycle and may lead to new strategies for controlling and treating malaria.
Researchers from NIAID and University of California, Berkeley develop a cell phone-based videomicroscope that provides fast and effective testing for L. loa parasites in blood samples, allowing dually-infected patients to be protected from ivermectin complications.
A study on guppy fish reveals how their immune genes evolve to resist parasites while maintaining critical function over millions of years. The research sheds light on the evolutionary dynamics of the immune system and its ability to adapt to new threats.
Researchers have identified two essential proteins, plasmepsin IX and X, which play critical roles in the life cycle of malaria parasites. Targeting these proteins could lead to the development of effective anti-malaria drugs.
Researchers at CNRS have identified a novel protein, KSRP, specific to the ribosomes of trypanosome parasites. Inhibiting its activity leads to parasite death. This discovery opens the path to developing new, safer therapies for Chagas disease and African sleeping sickness.
Researchers at the University of Edinburgh have made a significant discovery on how a harmful parasite harnesses energy, which could lead to new treatments. The study reveals that targeting a key enzyme linked to metabolism could be an effective way to kill the parasite without harming humans.
A new study suggests that reducing nutrient pollution in salt marshes could help prevent human disease. The research found that nutrient enrichment increased the number and biomass of parasites in a specific host species, which may have implications for human health.
Research shows fish modify behaviors to avoid parasites, with behaviorally-modified individuals displaying increased surface activities and reduced swimming. This discovery could lead to new strategies for preventing parasite infections in aquaculture.
Researchers discovered that carbohydrates on malaria parasites play a critical role in infecting human and mosquito hosts. The study suggests steps for improving the malaria vaccine, which has been only partially effective in preventing the disease.
Researchers seek to understand how trypanosome parasites cause long-term infections in cattle, with potential to develop novel ideas for prevention and treatment. The project aims to target the parasite's defences using drug therapy or vaccines.
A global analysis suggests that climate change could lead to the extinction of up to a third of parasite species by 2070. The study used museum collections and GPS coordinates to understand conservation risks. Parasite diversity is a key indicator of ecosystem health, highlighting their critical role in maintaining balance.
A new class of compounds, hexahydroquinolines (HHQs), shows promise in preventing Plasmodium falciparum parasite transmission from infected hosts to mosquitoes. HHQs also enhance the effectiveness of existing antimalarial treatments, making it harder for drug-resistant parasites to emerge.
Researchers from the University of Edinburgh studied two species of trypanosome parasites that can co-infect animals at once. Communication between the species may aid their survival by controlling numbers and optimizing transmission, potentially leading to more severe human infections.
Researchers from Florida Atlantic University are developing a Placenta-on-a-Chip device that simulates malaria in the womb to develop new treatments. The device uses embedded microsensors to monitor vascular cell well-being and nutrient circulation, enabling close examination of malaria's effects on mother and fetus.
Researchers have confirmed that a Dutch isolate of the parasite Cystoisospora suis is resistant to toltrazuril, a common treatment used in Europe. This development highlights the need for increased hygiene measures and monitoring of resistance to prevent the spread of resistant parasites.
Researchers found that wood frogs with pesticide tolerance are more susceptible to a deadly virus and a parasitic worm, while those far from agriculture have reduced susceptibility. This study highlights the complexity of pesticide-parasite interactions and the need to consider multiple stressors in environmental conservation.
Researchers used X-ray fluorescence microscopy and soft X-ray tomography to study malaria parasites in liquid nitrogen, gaining insights into their ravaging mode of operation. The findings suggest a potential mechanism controlling the speed of hemoglobin digestion and crystallization, which could be targeted with new medication.
Research finds that boat noise affects cleaner fish behavior, leading to increased cheating and decreased cleaning efficiency. This study highlights the need to control man-made noise in protected habitats.
Research reveals that dodder plants transmit herbivory-induced signals among host plants, triggering defense responses and reducing insect growth. The discovery showcases the complex ecological interactions between parasitic plants and their hosts.
Researchers found that amphibian susceptibility to parasites varies with proximity to agriculture and evolutionary responses to pesticides. Wood frogs living closer to agriculture with high baseline tolerance had lower trematode loads, while those far from agriculture with inducible pesticide tolerance had higher viral loads.
Researchers at The Francis Crick Institute and The London School of Hygiene & Tropical Medicine identified a key protein involved in malaria parasite escape. Disrupting this protein reduces the efficiency of parasite escape, slowing down infection rate.
A new study reveals that malaria parasites actively adapt to a host's nutritional status, with mice eating 30% fewer calories showing significantly lower parasite loads. The parasite's rate of replication depends on the host's calorie intake, potentially dictating the outcome of a malaria infection.
A research team used micro-computer tomography to investigate the relationship between parasite and host masses, finding a positive correlation. This suggests that larger hosts support larger parasites. The study also sheds light on the life-cycle of parasitic barnacles, revealing two groups with different competitive strategies.
Researchers at the University of York have found that parasites responsible for leishmaniasis are mainly acquired from the skin rather than through blood transfusions. This discovery challenges current treatment methods and highlights the importance of measuring parasite levels in the skin to assess treatment success.
A recent joint statement highlights the critical lack of knowledge on the worldwide distribution of disease-causing organisms, including viruses, bacteria, and parasites. Macroecologists propose creating a data network to close these gaps and predict future outbreaks.
The UW-led Malaria Evolution in South Asia research center is one of 10 NIH-supported International Centers of Excellence for Malaria Research. Researchers are studying the genetic diversity of malaria parasites in India, which shows more variation than elsewhere globally, making standard laboratory tests less accurate.
A new genetic technique developed by Upeksha Rathnapala and colleagues at the University of Melbourne could enhance research into potential drug targets for malaria treatment. By using a novel approach involving fluorescent markers, scientists can identify metabolic processes essential for Plasmodium development in host animals.
A newly described protein, PfAP2-I, regulates a number of genes involved with the parasite's invasion of red blood cells, making it an effective target for new antimalarial drugs. Preventing PfAP2-I from binding to DNA and initiating the expression of invasion genes could stop an infection before it reaches the red blood cell stage.
Researchers at LSTM and partners have developed a molecule, E209, effective against parasites with artemisinin resistance. The fully synthetic molecule is designed to be fast-acting and slowly eliminated, offering hope as a single-dose cure.
Researchers at NIAID developed a new malaria vaccine that protects monkeys against the deadly Plasmodium falciparum parasite. The vaccine elicited neutralizing antibodies in monkeys and showed improved efficacy compared to previous AMA1 vaccines.
Researchers have identified the neural basis for password-based species recognition in cowbirds, a behavior that resolves the paradox of species recognition in brood parasites. The study reveals that young cowbirds use a specific chatter call as a 'password' to identify conspecifics and avoid imprinting on host species.
Researchers studied mandrill behavior in Gabon's rainforests, finding they avoid sick individuals through olfactory cues. This 'behavioral immune system' minimizes parasite transmission, influencing social behavior and co-evolution.
Researchers from Vetmeduni Vienna found that the raccoon dog is a greater risk than the raccoon as a vector for local parasites. The study revealed the presence of fox tapeworm and other parasites in raccoon dogs, which also infest local foxes.
Research teams identified two cyclic peptides that can shut down an enzyme long thought to be undruggable for fighting disease-causing parasites and bacteria. The finding could lead to the development of new antimicrobial drugs.
Researchers at Imperial College London found that malaria parasites change the properties of red blood cells to facilitate entry, making them more susceptible to infection. This discovery suggests that naturally flexible cells may be easier for parasites to invade, prompting further investigation into host-directed therapies.
Scientists have identified two parasite proteins that allow Plasmodium falciparum malaria parasites to quickly traverse human cells and infect liver cells. This discovery could lead to the development of new antimalarial treatments and vaccines to combat the disease.
Researchers developed a comprehensive mathematical model of the deadliest malaria parasite Plasmodium falciparum metabolism. The model accurately integrates genetics and metabolism data, predicting which genes are indispensable for every biological function in the parasite.
A new mathematical model of Plasmodium falciparum's metabolism reveals its essential genes and thermodynamic bottlenecks, enabling potential mechanisms to target with drugs. The model integrates genetics and metabolomics data, allowing for the formulation of testable hypotheses and accelerating novel antimalarial drug discovery.
A comprehensive review of primate social networks and parasites highlights the importance of super-spreaders in disease transmission. Combining behavior data with parasite analysis can help identify high-risk traits and develop targeted interventions.
A study analyzing 24,000 blood samples from migratory and resident birds in the Americas found 79 malaria parasite lineages. The researchers discovered that prevalence varies between localities and species, with some areas having infection rates as high as 37%.
A team of researchers discovered that the parasite Trypanosoma brucei has an internal clock, enabling it to adjust its composition and functions according to the day-night cycle. This finding could lead to more efficient treatment with chronotherapy, a concept already applied in other diseases.
A new intervention developed by Bar-Ilan University scientists can control parasite migration by creating an unfavorable environment or damaging cell health. This research has the potential to lead to the development of drugs to treat and prevent diseases such as African sleeping sickness, leishmaniasis, and Chagas' disease.
An international team of researchers identified a core set of genes involved in honey bee responses to viruses and parasites. The findings provide new possibilities for breeding more resilient honey bee stocks and understanding pathogen interactions with other insects.
A clinical trial shows that Sanaria's PfSPZ Vaccine induces strain-transcending T cells and provides durable protection against both same and different malaria parasites. The 3-dose regimen offers long-lasting immunity, with 64% of subjects protected 19 weeks after the final dose.
Researchers at German Center for Infection Research develop a new malaria vaccine that uses fully viable malaria parasites, showing up to 100% protection against the disease. The vaccine was tested on 67 healthy adult subjects and showed strong immune responses.
An experimental malaria vaccine strategy, PfSPZ-CVac, combined with antimalarial medication protected all nine clinical trial volunteers given three high-dose vaccinations. The vaccine induced a response from T cells and identified 22 malaria parasite proteins that could be the targets of protective immune responses.